Having trouble accessing articles? Reset your cache.
Infectious disease company Chimerix Inc. (NASDAQ:CMRX) and hypertriglyceridemia company Omthera Pharmaceuticals Inc. (NASDAQ:OMTH) both priced IPOs on Thursday. Chimerix priced in the middle of
Get a two-week free trial subscription to BioCentury